{"id":"asprin-cilostazol","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Palpitations"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL799","moleculeType":"Small molecule","molecularWeight":"369.47"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Aspirin irreversibly inhibits cyclooxygenase (COX), reducing thromboxane A2 production and platelet aggregation. Cilostazol inhibits phosphodiesterase-3, increasing cAMP levels in platelets and vascular smooth muscle, further inhibiting platelet aggregation and promoting vasodilation. Together, they provide dual antiplatelet and vasodilatory effects.","oneSentence":"This combination of aspirin (antiplatelet) and cilostazol (phosphodiesterase-3 inhibitor) works synergistically to inhibit platelet aggregation and improve blood flow.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:42:09.140Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Secondary prevention of cardiovascular events in patients with peripheral arterial disease or coronary artery disease"},{"name":"Stroke prevention"}]},"trialDetails":[{"nctId":"NCT07180472","phase":"PHASE4","title":"Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Chengdu Medical College","startDate":"2025-09-20","conditions":"Cerebral Small Vessel Disease","enrollment":632},{"nctId":"NCT00333164","phase":"PHASE3","title":"Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis","status":"COMPLETED","sponsor":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","startDate":"2006-05","conditions":"Cerebrovascular Disease","enrollment":200},{"nctId":"NCT02266030","phase":"PHASE3","title":"Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2011-02","conditions":"Coronary Artery Disease","enrollment":100},{"nctId":"NCT00847860","phase":"PHASE4","title":"Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions","status":"COMPLETED","sponsor":"Peking University First Hospital","startDate":"2008-03","conditions":"Vascular Dementia, Stroke","enrollment":200},{"nctId":"NCT00741286","phase":"PHASE4","title":"Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler","status":"COMPLETED","sponsor":"Inje University","startDate":"2006-11","conditions":"Cerebral Infarction","enrollment":203}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Asprin, Cilostazol","genericName":"Asprin, Cilostazol","companyName":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","companyId":"translational-research-center-for-medical-innovation-kobe-hyogo-japan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination of aspirin (antiplatelet) and cilostazol (phosphodiesterase-3 inhibitor) works synergistically to inhibit platelet aggregation and improve blood flow. Used for Secondary prevention of cardiovascular events in patients with peripheral arterial disease or coronary artery disease, Stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}